MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

BACKGROUND: Lung adenocarcinoma patients with EGFR gene mutations have shown a dramatic response to gefitinib. However, drug resistance eventually emerges which limits the mean duration of response. With that in view, we examined the correlations between MET gene status as assessed by fluorescence i...

Descripción completa

Detalles Bibliográficos
Autores principales: Noro, Rintaro, Seike, Masahiro, Zou, Fenfei, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Matsumoto, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437672/
https://www.ncbi.nlm.nih.gov/pubmed/25886066
http://dx.doi.org/10.1186/s12885-015-1019-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437672/
https://www.ncbi.nlm.nih.gov/pubmed/25886066
http://dx.doi.org/10.1186/s12885-015-1019-1

Ejemplares similares